Company intelligence / Profile preview

Disrupt Pharma Tech

Dover, Delaware, United Statesvc4a.com ↗

Ownership: Private
Development stage: Commercial

Overview

Disrupt Pharma Tech Africa operates as a technology-driven service provider under the brand "Medsaf," focusing on improving access to safe medicines by solving information and logistics problems in the pharmaceutical supply chain of emerging markets. Their digital platform leverages data analytics and proprietary software to connect healthcare stakeholders with quality-assured medications, vaccines, and consumables. The company has served over 750 clients across Nigeria's healthcare sector with significant growth since the pandemic.

Therapeutic areas: Other
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Disrupt Pharma Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disrupt Pharma Tech.

Explore the full profile